Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

227 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Melanoma and Non-Melanoma Skin Cancers].
Uhara H. Uhara H. Gan To Kagaku Ryoho. 2024 Apr;51(4):392. Gan To Kagaku Ryoho. 2024. PMID: 38644303 Japanese. No abstract available.
[Melanoma and Non-Melanoma Skin Cancers].
Uhara H. Uhara H. Gan To Kagaku Ryoho. 2022 Apr;49(4):407-408. Gan To Kagaku Ryoho. 2022. PMID: 35444122 Japanese. No abstract available.
[Melanoma].
Uhara H. Uhara H. Gan To Kagaku Ryoho. 2016 Apr;43(4):404-7. Gan To Kagaku Ryoho. 2016. PMID: 27220785 Japanese.
[BRAF inhibitor and MEK inhibitor].
Uhara H. Uhara H. Gan To Kagaku Ryoho. 2015 Apr;42(4):428-33. Gan To Kagaku Ryoho. 2015. PMID: 26020982 Japanese. No abstract available.
Phase 1b study of pembrolizumab (MK-3475; anti-PD-1 monoclonal antibody) in Japanese patients with advanced melanoma (KEYNOTE-041).
Yamazaki N, Takenouchi T, Fujimoto M, Ihn H, Uchi H, Inozume T, Kiyohara Y, Uhara H, Nakagawa K, Furukawa H, Wada H, Noguchi K, Shimamoto T, Yokota K. Yamazaki N, et al. Among authors: uhara h. Cancer Chemother Pharmacol. 2017 Apr;79(4):651-660. doi: 10.1007/s00280-016-3237-x. Epub 2017 Mar 11. Cancer Chemother Pharmacol. 2017. PMID: 28283736 Free PMC article. Clinical Trial.
Systemic therapy for Asian patients with advanced BRAF V600-mutant melanoma in a real-world setting: A multi-center retrospective study in Japan (B-CHECK-RWD study).
Namikawa K, Ito T, Yoshikawa S, Yoshino K, Kiniwa Y, Ohe S, Isei T, Takenouchi T, Kato H, Mizuhashi S, Fukushima S, Yamamoto Y, Inozume T, Fujisawa Y, Yamasaki O, Nakamura Y, Asai J, Maekawa T, Funakoshi T, Matsushita S, Nakano E, Oashi K, Kato J, Uhara H, Miyagawa T, Uchi H, Hatta N, Tsutsui K, Maeda T, Matsuya T, Yanagisawa H, Muto I, Okumura M, Ogata D, Yamazaki N. Namikawa K, et al. Among authors: uhara h. Cancer Med. 2023 Sep;12(17):17967-17980. doi: 10.1002/cam4.6438. Epub 2023 Aug 16. Cancer Med. 2023. PMID: 37584204 Free PMC article.
227 results